MYCOSIS FUNGOIDES/SEZARY SYNDROME
Clinical trials for MYCOSIS FUNGOIDES/SEZARY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MYCOSIS FUNGOIDES/SEZARY SYNDROME trials appear
Sign up with your email to follow new studies for MYCOSIS FUNGOIDES/SEZARY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for rare skin cancers in early trial
Disease control OngoingThis early-phase study tests a new drug called tulmimetostat (DZR123) in 24 adults with advanced mycosis fungoides or Sezary syndrome, rare types of skin lymphoma. Participants must have already tried at least one prior treatment. The main goals are to check the drug's safety and…
Matched conditions: MYCOSIS FUNGOIDES/SEZARY SYNDROME
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Drug combo shows promise for rare skin cancer
Disease control OngoingThis study tests whether combining pembrolizumab (an immunotherapy) with gemcitabine (a chemotherapy drug) can help control advanced mycosis fungoides or Sézary syndrome, two rare types of skin lymphoma. It includes 14 adults who have already tried at least one other treatment. T…
Matched conditions: MYCOSIS FUNGOIDES/SEZARY SYNDROME
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:43 UTC